期刊文献+

急性心肌梗死伴发肾动脉粥样硬化性狭窄患者的预后分析 被引量:1

Prognostic analysis of atherosclerotic renal artery stenosis sclerosing in patients with acute myocardial infarction
原文传递
导出
摘要 目的:观察急性心肌梗死伴发肾动脉粥样硬化性狭窄(atherosclerotic renal artery stenosis,ARAS)≥70%患者的远期预后。方法:收集205例急性心肌梗死患者临床资料,患者同时进行了冠状动脉和肾动脉血管造影检查,随访主要心脑血管不良事件:死亡、脑卒中、心力衰竭、非致死性心肌梗死及冠脉血运重建。复合终点事件是指任何上述不良事件。结果:随访期间共有31例(15.1%)出现心力衰竭,其中ARAS患者10例(25.6%),非ARAS患者21例,二者差异有统计学意义(P=0.049);ARAS患者中有22例(56.4%)出现复合终点事件,非ARAS患者中有38例(22.9%)出现复合终点事件,二者差异有统计学意义(P=0.000);多因素Cox回归分析显示,ARAS是急性心肌梗死后发生心力衰竭的预测因素。结论:ARAS与发生心力衰竭相关,并与远期发生主要心脑血管不良事件的复合终点相关。 Objective:To observe the effect of atherosclerotic artery renal artery stenosis (ARAS) ≥70% on long-term prognosis in patients with acute myocardial infarction (AMI). Methods: All 205 cases with AMI had underwent coronary and renal artery angiography. The main cardiovascular and cerebrovascular adverse events including death, stroke, heart failure, nonJfatal myocardial infarction and revascularization were monitored during follow-up. Composite endpoints were defined as occurrence of the above adverse events. Results: Thirty-one patients (15.1%) suffering heart failure. Heart failure occurred in 10 patients (25.6%) with ARAS, while in 21 patients (12.7%) without-ARAS (P=0. 049). Composite events occurred in 22 patients (56.4%) with ARAS, while in 38 patients (22.9%) without-ARAS, there was a significant difference between the two groups (P= 0. 000). Cox regression analysis showed that only ARAS predicted heart failure in paients with AMI. Conclusion: ARAS is related to the occurrence of heart failure and the composite endpoint of long-term adverse events.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第10期738-741,共4页 Journal of Clinical Cardiology
关键词 急性心肌梗死 粥样硬化性肾动脉狭窄 心力衰竭 预后 acute myocardial infarction atherosclerotic renal artery stenosis ARAS heart failure prognosis
  • 相关文献

参考文献3

二级参考文献24

  • 1SONG Xian-tao CHEN Yun-dai PAN Wei-qi LU Shu-zheng.Gender based differences in patients with acute coronary syndrome:findings from Chinese Registry of Acute Coronary Events (CRACE)[J].Chinese Medical Journal,2007(12):1063-1067. 被引量:9
  • 2HAGE F G, VENKATARAMAN R, ZOGHBI G, et al. The scope of coronary heart disease in patients with chronic kidney disease[J]. J Am Coll Cardiol. 2009,53:2129-2140.
  • 3MUNTNER P, HE J, HAMM L. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States[J]. J Am Soc Nephrol. 2002,13:745-753.
  • 4LAMBERT N D, SACRINTY M T, KETCH T R. et al. Chronic kidney disease and dipstick protcinuria arerisk factors for stent thrombosis in pavients with myocar dial infarction[J]. Am Heart J.2009.157:688 -691.
  • 5ZHU Z B, ZHANG R Y, ZHANG Q. et al. Moderate-severe renal insufficiency is a risk factorr for sirolimus-eluting stent thrombosis. The RIFT study J .Cardiology, 2009 112:191-199.
  • 6LATIF F, KI.EIMAN N S, COHEN D J, et al. Inhospital and 1-year outcomes among percutaneous cor- onary intervention patients with chronic kidney disease in the era of drug-elnting stents: a report from the E- VENT (Evaluation of Drug Eluting Stents and lschemic Events) registry[J]. J Am Coll Cardiot Inlv. 2009,2.37-45.
  • 7BEST P J, LENNON R, TING H It, et al. The im- pact of renal insufficiency on clinical outcomes in nai tients undergoing pereutaneous coronary intervemins[J]. J AmCollCardiol,2002,33:1113-1119.
  • 8BEST P J, STEINHUBL S R, BERGER P B. et al. The efficacy and safety of short and long-term dual anti- platelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Re duetion of Events During Observation (CRF.1)()) trial [J]. Am HeartJ,2008,155:687-693.
  • 9DASGUP'FA A, STEINHUBI. S R, BHATT D I, et al. Clinical outcomes of patients with diabelie nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the Clopidogrel for High Atherothrombotic Risk and lschemic Stabilization, Management,and Avoidance ECHARISMAd trial)[J]. AmJCardiol,2009,103:1359-1363.
  • 10TANTRY U S, BLIDEN K P, GURBEL P A. Overestimation of platelet aspirin resistance detection by throm- belastograph platelet mapping ad validation hy conventional aggregometry using arachidonic acid stimulation [J]. JArn Coll Cardiol, 2005,46 : 1705 - 1709.

共引文献13

同被引文献51

  • 1Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) [J]. Eur J Heart Fail, 2008,10(10) : 933-989. DOI: 10. 1016/j. ejheart. 2008.08. 005.
  • 2Go AS, Mozaffarian D, Roger VL, et al. Executive summary : heart disease and stroke statistics-2014 update: a report from the American Heart Association [ J ]. Circulation, 2014,129 ( 3 ) : 399- 410. DOI: 10.1161/'01. cir. 0000442015. 53336.12.
  • 3Ma Q, Zheng B, Meng K, et al. A simple score for predicting renal artery stenosis in patients with ischemic heart disease[ J]. Int J Clin Exp Med, 2015,8(3) :4302-4310.
  • 4Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiae and resynehronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association[J]. Eur Heart J, 2010,31 (21) :2677- 2687. DOI: 10. 1093/eurheartj/ehq337.
  • 5Heron M. Deaths : leading causes for 2007 [ J ]. Natl Vital Stat Rep, 2011,59(8) :1-95.
  • 6Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association[ J]. Circulation, 2013,127 ( 1 ) : 143- 152. DOI: 10. 1161/CIR. 0bO13e318282ab8f.
  • 7Pullicino P, Homma S. Stroke in heart failure: atrial fibrillation revisited? [ J]. J Stroke Cerebrovasc Dis, 2010, 19 ( 1 ) : 1-2. DOI : 10. 1016/j. jstrokecerebrovasdis. 2009.09. 002.
  • 8Alberts VP, Bos MJ, Koudstaal P, et al. Heart failure and the risk of stroke: the Rotterdam Study[J]. Eur J Epidemiol, 2010, 25 ( 11 ) :807-812. DOI: 10. 1007/s10654-010-9520-y.
  • 9Witt BJ, Brown RD Jr, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study [ J ]. Am Heart J, 2006, 152(1) :102-109. DOI: 10. 1016/j. ahj. 2005.10. 018.
  • 10Putaala J, Haapaniemi E, Metso A J, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke [ J ]. Ann Neurol, 2010,68(5) :661-671. DOI: 10. 1002/ana. 22091.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部